Notable Call Options Activity in Acorda Therapeutics
Shares of Acorda Therapeutics (NASDAQ: ACOR) are lower on the session by 0.38%, currently trading at $20.93. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average.
Options traders are focusing on calls today. A short while ago the November 2011 $20.00 call traded 1,500 times on open interest of 20 contracts.
Calls are outpacing puts today by 1,000 to 1.
Acorda Therapeutics, Inc. is a commercial-stage biopharmaceutical company engaged in the identification, development and commercialization of therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury, and other disorders of the nervous system.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.